Mitrade Insights is dedicated to providing investors with rich, timely and most valuable financial information to help investors grasp the market situation and find timely trading opportunities.

2021

Best News & Analysis Provider

FxDailyInfo

2022

Best Forex Educational Resources Global

International Business Magazine

Insights

News

2 Surefire Dividend Stocks That Could Pay You for Life

Source The Motley Fool

Dividend investing is an excellent strategy for (at least) two reasons. Companies that can provide consistent payouts generally have robust underlying operations. Also, reinvesting the dividend can significantly boost long-term returns.

However, dividend stocks aren't all equal -- it's essential to put your hard-earned money in companies that are unlikely to reduce or slash their payouts anytime soon, preferably ever. Here are two companies that can pull it off: Amgen (NASDAQ: AMGN) and Coca-Cola (NYSE: KO).

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »

1. Amgen

Amgen paid its first dividend in 2011. Since then, it has increased its payouts consistently:

AMGN Dividend Chart

AMGN Dividend data by YCharts.

The biotech could keep that up for a long time, given its excellent prospects. Amgen is a leading drugmaker with a lineup of medicines across many therapeutic areas. In 2024, the company had 13 products that each generated more than $1 billion in sales.

True, some of them are losing steam due to competition, whether biosimilar or otherwise, but others are stepping up. In 2024, Amgen recorded $972 million in sales (increasing 71% year over year) from its asthma medicine, Tezspire, the rights to which it shares with AstraZeneca. This therapy recently aced a phase 3 study for the treatment of chronic rhinosinusitis (inflamed sinuses), so expect a label expansion in this indication. Several more of the company's medicines should earn plenty of new indications.

Amgen is also developing brand-new ones. Amgen's work in the weight management market has been noteworthy of late. Though the company's leading candidate in this field, MariTide, didn't quite live up to market expectations in a phase 2 clinical trial, it's too early to give up on this project. The company is running two phase 3 studies for MariTide in obesity and diabetes.

Amgen's work goes far beyond MariTide; its late-stage pipeline alone features 33 programs. Thanks to its large portfolio of investigational products, the company looks set to develop newer medicines consistently and deliver strong financial results, helping support its excellent dividend program. Amgen is highly unlikely to suspend or even cut its payouts anytime soon, making it an excellent pick for income seekers.

2. Coca-Cola

Beverage behemoth Coca-Cola has increased its payouts for 63 consecutive years; this makes it part of the elite club of Dividend Kings. You can count on two hands the number of companies with a more impressive streak than Coca-Cola in this department.

However, the past can't tell us everything. Even if Coca-Cola has had an incredible dividend history, we still need to do more work and look at the company's business and prospects. Fortunately, investors have little to fear.

That's not because Coca-Cola doesn't face any headwinds -- it has had its share of problems in the past few years, including severe pandemic-related disruptions to its business that led to significant drops in the company's sales. However, Coca-Cola survived that ordeal and has a business well-equipped to continue thriving for a long time.

Coca-Cola has a deep portfolio of products. While it's best known for its soft drinks, it offers options in most categories consumers can find on the shelves of local grocery stores, from water and tea to juice and coffee, sports drinks, and even some alcoholic options.

The company operates in more than 200 countries worldwide. Coca-Cola benefits from a powerful competitive advantage: a strong brand name that most people worldwide recognize and immediately trust. Coca-Cola caters to all kinds of customers, and adapts its strategy based on market demands in various regions.

And when consumer preferences change, Coca-Cola is flexible enough to modify its product portfolio accordingly. These factors have allowed the company to generate consistent revenue and earnings for a long time, and its strong standing in its industry should allow it to keep things going. The streak is alive and well. Coca-Cola has what it takes to maintain a growing dividend program for many years to come.

Should you invest $1,000 in Amgen right now?

Before you buy stock in Amgen, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Amgen wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $682,965!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of March 24, 2025

Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amgen. The Motley Fool recommends AstraZeneca Plc. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.

Recommended Articles

Fed hike odds near 90% into Wednesday's decision — how to trade the dollar, gold and the S&P 500 A 0.3% monthly core CPI print has lifted the market-implied probability of a 25bp Fed hike on 16 September to roughly 86.5% ~ 90%, which would be the first increase since July 2023. Here is the decision timeline, the pricing versus the forecasts, both scenarios, and the key levels for the dollar, gold and the S&P 500.

Author Suzie

Sep 14, Mon

A 0.3% monthly core CPI print has lifted the market-implied probability of a 25bp Fed hike on 16 September to roughly 86.5% ~ 90%, which would be the first increase since July 2023. Here is the decision timeline, the pricing versus the forecasts, both scenarios, and the key levels for the dollar, gold and the S&P 500.

Silver breaks $64 as precious metals rebound — can gold hold the $4,280 line into the Fed decision?Silver has climbed back above $64 an ounce for the first time this week, leading a broad rebound across precious metals hours before the Federal Reserve delivers what is expected to be its first rate hike since 2023. Spot silver was last at $64.64, up 1.49% on the day, while gold reclaimed $4,300 and platinum and palladium both advanced. The question now is whether the bounce is a genuine turn — or a pause before the Fed's dot plot decides the next move.

Author Suzie

Sep 16, Wed

Silver has climbed back above $64 an ounce for the first time this week, leading a broad rebound across precious metals hours before the Federal Reserve delivers what is expected to be its first rate hike since 2023. Spot silver was last at $64.64, up 1.49% on the day, while gold reclaimed $4,300 and platinum and palladium both advanced. The question now is whether the bounce is a genuine turn — or a pause before the Fed's dot plot decides the next move.

Bitcoin falls below $75,000 as the CLARITY Act fails in the Senate — what the vote means for crypto The US Senate blocked the Digital Asset Market CLARITY Act in a 49-50 procedural vote, sending Bitcoin briefly below $75,000 — its biggest one-day drop since June. Ethereum fell more than 8%, Coinbase slid 10% and $75 billion of crypto market value evaporated. Here is what the vote was, why it failed, and the levels that matter now.

Author Suzie

Sep 16, Wed

The US Senate blocked the Digital Asset Market CLARITY Act in a 49-50 procedural vote, sending Bitcoin briefly below $75,000 — its biggest one-day drop since June. Ethereum fell more than 8%, Coinbase slid 10% and $75 billion of crypto market value evaporated. Here is what the vote was, why it failed, and the levels that matter now.

Dow drops 631 points as the Fed hikes — but futures are rebounding: what's next for US stocks?The Dow fell 631 points and the S&P 500 closed below 7,600 after the Fed hiked rates for the first time since 2023, with the dot plot showing 16 of 18 officials expect more tightening. Asia-session futures are already recovering — here are the levels and analyst views that decide whether 7,500 holds.

Author Irene Q.

Yesterday 02: 54

The Dow fell 631 points and the S&P 500 closed below 7,600 after the Fed hiked rates for the first time since 2023, with the dot plot showing 16 of 18 officials expect more tightening. Asia-session futures are already recovering — here are the levels and analyst views that decide whether 7,500 holds.

Dollar index tops 100 for the first time since July as the Fed's hawkish dot plot sinks in The U.S. dollar index broke back above 100 for the first time since 31 July after the Fed delivered its first rate hike since 2023, with the dot plot showing 16 of 18 officials expect at least one more increase this year. Here are the levels that matter for DXY, the currencies feeling it most, and what to watch next.

Author Irene Q.

Yesterday 02: 45

The U.S. dollar index broke back above 100 for the first time since 31 July after the Fed delivered its first rate hike since 2023, with the dot plot showing 16 of 18 officials expect at least one more increase this year. Here are the levels that matter for DXY, the currencies feeling it most, and what to watch next.

Popular Symbols